Who owns Zentalis Pharmaceuticals, Inc.?
Institutional ownership of ZNTL from SEC Form 13F filings across 76 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
76
13F holders
$117.5M
value, 2026 filers
37.9%
of shares outstanding (27.0M sh)
24
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of ZNTL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.8M | $18.2M | 0.0% | 5.3% | +195.6% |
| 2 | TWO SIGMA INVESTMENTS, LP | 3.0M | $14.7M | 0.0% | 4.2% | +2.3% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.8M | $13.8M | 0.0% | 4% | -38.6% |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 2.7M | $12,995 | 0.0% | 3.8% | -5.8% |
| 5 | CITADEL ADVISORS LLC | 2.3M | $11.1M | 0.0% | 3.2% | +32.7% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $6.2M | 0.0% | 1.8% | +106.8% |
| 7 | BANK OF AMERICA CORP /DE/ | 1.1M | $5.4M | 0.0% | 1.6% | -1.6% |
| 8 | PRIMECAP MANAGEMENT CO/CA/ | 957,420 | $4.6M | 0.0% | 1.3% | 0.0% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 808,548 | $3.9M | 0.0% | 1.1% | +124.2% |
| 10 | Connor, Clark & Lunn Investment Management Ltd. | 758,033 | $3.7M | 0.0% | 1.1% | -4.3% |
| 11 | MILLENNIUM MANAGEMENT LLC | 664,281 | $3.2M | 0.0% | 0.9% | -48.5% |
| 12 | MARSHALL WACE, LLP | 591,473 | $2.9M | 0.0% | 0.8% | +50.6% |
| 13 | Qube Research & Technologies Ltd | 574,806 | $2.8M | 0.0% | 0.8% | -9.8% |
| 14 | D. E. Shaw & Co., Inc. | 546,566 | $2.7M | 0.0% | 0.8% | -63.2% |
| 15 | MORGAN STANLEY | 471,250 | $2.3M | 0.0% | 0.7% | +34.6% |
| 16 | NORTHERN TRUST CORP | 388,299 | $1.9M | 0.0% | 0.5% | +228.5% |
| 17 | GOLDMAN SACHS GROUP INC | 372,564 | $1.8M | 0.0% | 0.5% | -19.5% |
| 18 | VANGUARD FIDUCIARY TRUST CO | 336,940 | $1.6M | 0.0% | 0.5% | +10.7% |
| 19 | FMR LLC | 310,264 | $1.5M | 0.0% | 0.4% | +9.3% |
| 20 | UBS Group AG | 297,378 | $1.4M | 0.0% | 0.4% | +91.0% |
| 21 | Creative Planning | 285,000 | $1.4M | 0.0% | 0.4% | 0.0% |
| 22 | SEI INVESTMENTS CO | 256,079 | $1.2M | 0.0% | 0.4% | +33.7% |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 215,113 | $1.0M | 0.0% | 0.3% | -62.3% |
| 24 | Sixth Street Partners Management Company, L.P.NEW | 171,911 | $833,768 | 0.1% | 0.2% | new |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 171,911 | $833,768 | 0.0% | 0.2% | +236.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.